IQ-AI Limited AGM Statement (2406A)
23 May 2023 - 4:00PM
UK Regulatory
TIDMIQAI
RNS Number : 2406A
IQ-AI Limited
23 May 2023
IQ-AI Limited
("IQ-AI" or the "Company")
AGM Statement
IQ-AI Limited is due to hold its AGM today. At the AGM, the
Chairman will announce the following:
-- Over 200 more datasets have been received in collaboration
with Phoenix Children's Hospital. These datasets will be used for
the continued development of Artificial Intelligence (AI) imaging
technologies targeted to aid pediatric patients. Quality training
data improves AI performance and the AI models already in
development for adult patients can easily be trained using
pediatric datasets.
-- The Phase I clinical trial maintains strong momentum,
enrolling subjects at the final dose level and into the expansion
phase (where a larger number of patients are treated to further
assess the safety of the final dose).
-- In the USA, May is recognized as Brain Tumor Awareness month;
a month dedicated to raising awareness. In support of this
initiative, a local (Wisconsin, USA) TV outlet will interview Dr.
Jennifer Connelly later this month to showcase the Phase I Clinical
Trial being conducted at the Medical College of Wisconsin. Joining
Dr. Connelly will be one of the trial participants.
-- Following a successful appearance at the ASNR (American
Society of Neuroradiology) conference in Chicago earlier this
month, Imaging Biometrics LLC ("IB") is exploring two academic
collaborations for the commercialization of novel and emerging
imaging technologies.
-- A product development milestone was met for enabling
longitudinal reporting capabilities. This accomplishment lays the
foundation for reporting of IB's quantitative output over time to
assess treatment response in patients.
Trevor Brown, Chair said "Progress continues steadily across all
activities as prospects continue to brighten. I am looking forward
to updating shareholders as the year unfolds."
The Directors of the Company accept responsibility for the
contents of this announcement.
-ENDS-
For further information, please contact:
IQ-AI Limited
Trevor Brown/Brett Skelly/Vinod Kaushal
Tel: 020 7469 0930
Peterhouse Capital Limited (Financial Adviser and Broker)
Lucy Williams/Heena Karani
Tel: 020 7220 9797
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
AGMBSGDUCDDDGXD
(END) Dow Jones Newswires
May 23, 2023 02:00 ET (06:00 GMT)
Iq-ai (LSE:IQAI)
Historical Stock Chart
From Dec 2024 to Jan 2025
Iq-ai (LSE:IQAI)
Historical Stock Chart
From Jan 2024 to Jan 2025